Background and objectives: Hydroxyethyl starch (HES) 130/0.4 is considered an effective plasma expander when compared to crystalloids. There is controversy around its superiority regarding hemodynamic optimization and about possible detrimental effects on coagulation. The aim of this study was to compare the effects of HES 130/0.4 to lactated Ringer solution during hip arthroplasty in adult patients under spinal anesthesia regarding intraoperative bleeding, hemodynamic parameters, coagulation profi le, transfusion requirements and clinical outcomes. Methods: In this randomized, controlled trial, 48 patients scheduled for hip arthroplasty with spinal anesthesia were randomized into two groups: 24 patients were allocated to receive a preload of 15 mL.kg -1 of HES 130/0.4 and 24 patients received a preload of 30 mL.kg -1 lactated Ringer solution before surgery. Hemodynamic measurements, hemoglobin concentrations, biochemical parameters and coagulation tests were evaluated in three periods during surgical procedure. Patients received medical follow-up during their hospital stay and up to postoperative 30 days. Primary outcome was the requirement of red blood cell transfusion between groups during hospital stay. Secondary outcome were hemodynamic parameters, length of hospital stay, mortality and occurrence of clinical postoperative complications.
Introduction
The best type of fl uid for intravascular volume replacement in major surgeries remains a matter of controversy 1 . Synthetic colloids seem to be more attractive because of their ability to maintain intravascular fl uid volume and regional tissue perfusion more effi ciently than crystalloids [2] [3] [4] . However, colloid solutions such as hydroxyethyl starchs (HES), gelatin and dextran, when compared to crystalloid solutions are more expensive and may be associated with adverse effects, such as acute renal failure, and platelet and coagulation disorders 5, 6 .
Third-generation HES -as HES 130/0.4 and HES 130/0.42 -relate to less adverse effects ratio, probably due to structural moieties, as they present lower molecular weight and the degree of molar substitution, compared to other HES solutions 7, 8 .
A multicenter randomized trial showed that allogenic transfusion increases morbidity and mortality rates in critically ill patients 11 . Adverse risks associated with blood transfusion include higher infection rates, immunologic risks and increase in costs [12] [13] [14] [15] . Pharmacologic agents such as tranexamic acid or aminocaproic acid (EACA) could reduce perioperative blood loss by interfering with fi brinolysis 16 . Numerous small trials evaluated the use of antifi brinolytics in orthopedic surgery, observing their effi ciency in reducing blood loss. Unfortunately, they were underpowered to detect effi cacy on more relevant clinical outcomes. Furthermore, the remaining concern is that such agents may promote a hypercoagulable state within the context of high risk of venous thromboembolism, such as in orthopedic surgery 17, 18 .
This prospective, randomized and controlled study was performed to compare the effects of HES 130/0.4 with lactated Ringer solution during hip arthroplasty in adult patients under spinal anesthesia regarding transfusion requirements, hemodynamic parameters and clinical postoperative complications.
Methods

Study Design and Treatment Strategies
We performed a prospective, randomized and controlled trial that enrolled consecutive patients scheduled for elective hip arthroplasty at the Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Universidade de São Paulo, Brazil, during a 24-month period. Patients were excluded for any of the following reasons: age younger than 18 years; obesity (BMI > 40 kg.m -2 ); chronic kidney disease (creatinine clearance lower than 60 mL.min -1 .m -2 ); American Society of Anesthesiologists (ASA) physical status classifi cation III or higher; chronic anemia (preoperative hemoglobin lower than 10 g.dL -1 ); low platelet count (preoperative platelet count lower than 150x10 3 .μL -1 ); coagulopathy (previous history or prothrombin time longer than 14.8 seconds); left ventricular dysfunction (left ventricular ejection fraction lower than 40%); myocardial infarction during the last 6 months, unstable angina, hepatic dysfunction (total bilirubin level higher than 1.5 mg.dL -1 ); and refusal to consent.
The study was approved by the Ethics Committee, Hospital das Clínicas, Universidade de São Paulo, and written informed consent was obtained from all patients before enrollment.
Patients were randomly assigned to the HES group or lactated Ringer group at a proportion of 1:1. Opaque envelopes arranged using a random-number table were prepared by the chief statistician and opened sequentially to determine the patient´s treatment group. The research coordinator enrolled the participants and obtained informed consent. Information about the treatment was given to the anesthesiologist. Patients and the outcome assessors were blinded to group assignments.
Immediately after anesthetic procedure, patients assigned to the HES group received 15 mL.kg -1 intravenous of HES 6% 130/0.4 and patients assigned to lactated Ringer group received 30 mL.kg -1 intravenous of lactated Ringer. The trigger for additional fl uid replacement was a systolic blood pressure lower than 90 mm Hg and/or a decrease of 20% from baseline, or heart rate higher than 100 beats per minute. Vasopressors were used if there was persistent hypotension despite fl uid replacement. Red blood cell transfusion was administered in patients with hemodynamic instability (mean arterial pressure lower than 65 mm Hg despite of adequate fl uid replenishment) associated with hemoglobin lower than 8 g.dL -1 .
Anesthesia protocol
Patients were premedicated with 5 mg of intravenous midazolam in the pre-induction anesthetic room. All patients were monitored with non-invasive blood pressure, continuous electrocardiography and pulse oximetry. A peripheral catheter 16G under local anesthesia was inserted in the cubital vein. Arterial and central venous catheters were placed as required. Lumbar spinal anesthesia, preferably into L3/L4 space with a 27G needle, was performed. A mixture of isobaric bupivacaine 20 mg plus morphine 100 μg was used in all patients. Sedation with intravenous propofol 0.1μg.kg -1 was administered in all patients during the surgical procedure. Hypothermia was prevented during the surgery and recovery period with the use of a heating blanket and warmed intravenous fl uids. After surgical procedure, all patients were transferred to post-anesthetic unit care until complete
Baseline Assessment and Data Collection
At the time of randomization, demographic and clinical data were obtained for each patient. Preoperative laboratory values collected up to 24 hours before surgery were recorded and included: hemoglobin, hematocrit, prothrombin time, active partial thromboplastin time, creatinine level, bilirubin level, and platelet count. During surgery, arterial pressure, heart rate and pulse oxymetry were recorded immediately before and after the regional anesthesia, every 15 minutes until the end of the surgery, as well as in the recovery room. Blood samples for measurement of hemoglobin levels, arterial blood gas analysis and assessment of coagulation and platelet aggregation were collected just before the surgery, 2 hours after the incision, at the end of the surgery and after 24 hours of the surgical procedure. Platelet aggregation was assessed by light transmission aggregometry using a PAP-4 aggregometer after ADP infusion [19] [20] .
Blood losses from the surgical fi eld were calculated by computing the amount of blood in surgical aspirators, and by weighing surgical sponges during the procedure. In the remaining 24 hours of the postoperative period, blood losses were considered by obtaining the volume from tube drainage. All administered intravenous fl uids and red blood cells were recorded from the beginning of the surgery until the fi rst 24 hours after the surgical procedure.
During patients' hospital stay, data were collected regarding the use of RBC transfusion and clinical complications. Clinical outcomes were evaluated in a blinded fashion.
Hematological complications were defi ned as impairment of platelet aggregation and increase in blood losses during perioperative and within the fi rst 24 hours of postoperative period. Respiratory complications were defi ned as the need for mechanical ventilation and development of pneumonia or acute respiratory distress syndrome (ARDS) defi ned by standard criteria 21 . Cardiac complications included cardiogenic shock, tachyarrhythmia or perioperative cardiac ischemia 22 .
Renal function was evaluated daily using RIFLE (Renal risk, Injury, Failure, Loss of kidney function, End-stage kidney disease) classifi cation 23 . The need for renal replacement therapy was recorded.
Infectious complications included: septic shock -defi ned by standard criteria); pneumonia -defi ned by a new lung infi ltrate on chest radiography and the presence of at least two of the following criteria: temperature of 38ºC or higher, leukocytosis greater than 12,000 cells. μL -1 or leucopenia lower than 3,000 cells.μL -1 , or purulent endotracheal secretions with a Gram stain showing more than 25 neutrophils and fewer than 10 epithelial cells per fi eld; wound infection -defi ned as a superfi cial or deep infection of the wound with positive fi ndings on cultures obtained from the wound 24 .
Outcome Measures
The primary outcome was red blood transfusion requirement from operation time until 30 days after surgical procedure. Secondary outcomes included a comparison of hemodynamic variables and tissue perfusion parameters between groups during the surgical procedure, and postoperative incidence of all complications, including infectious, hematological, cardiovascular, respiratory and renal complications, and hospital length of stay.
Statistical Analysis
The sample size was calculated assuming a 40% incidence in transfusion requirement in crystalloid group. Considering an alpha error of 0.05 and a statistical power of 0.80, we determined that a minimum of 23 patients in each group was necessary to conduct the present study.
Results are expressed as means with 95% confi dence intervals (CIs) or medians with interquartile ranges (IQR). Continuous variables were compared using a t test or Mann-Whitney U test and categorical variables using Pearson chi-square or Fisher's exact test. The differences between and within the groups were analyzed with one-way analysis of variance on ranks. Tests were 2-tailed, and values of p < 0.05 were considered statistically signifi cant. Statistical analyses were performed using SPSS version 18.0 (SPSS Inc, Chicago, Illinois).
Results
A total of 48 patients were enrolled in the study: 24 assigned to the HES group 130/0.4 and 24 in the lactated Ringer group. Baseline characteristics were well matched between study groups (Table 1) . Anesthetic requirements and duration of surgery were also similar in the groups. There was no difference regarding intraoperative body temperature and hemodynamic parameters -heart rate, systolic and diastolic pressures between groups ( Table 2) . No difference was found with regards to urinary output, need for norepinephrine, inotropic support and additional fl uid administration.
Coagulation parameters, hemoglobin and hematocrit values at different times were similar in both groups ( Table 3 ). The analysis of arterial blood gas did not reveal any difference between groups in values of arterial pH, partial pressure of oxygen, partial pressure of carbon dioxide, base excess and bicarbonate (Table 4 ). Biochemical analysis was not different between groups (Table 5 ) .
Clinical Outcomes
Perioperative Blood Transfusion
In the Ringer group, 11 patients (46%) needed RBC transfusion during hospital stay compared to four patients (17%) in the HES group (p = 0.029) ( Figure 1 ).
Platelet Aggregation
Platelet aggregation tests were signifi cantly impaired in the HES group when compared to lactated Ringer group ( Figure 2 ). D = the difference between groups was demonstrated immediately after HES infusion (p = 0.042), after two hours (p = 0.029) and at the end of surgical procedure (p = 0.029). 30 A. Hamaji et al. 
Perioperative Blood Loss
The total amount of blood loss was signifi cantly higher in HES group (mean 1.296 mL ± 673.24 in HES group versus 890.00 ± 566.54 mL in lactated Ringer group; p < 0.0460) ( Figure 3 ).
Secondary Outcomes
There were no signifi cant differences between groups in hospital mortality or in length of stay either in the postanesthetic care unit or in regular wards (Table 6 ). There were no differences in the occurrence of cardiac complications, respiratory complications or renal complications. Patients treated with lactated Ringer had a higher number of infectious complications (4/24, 17%) than the HES group (0) (p = 0.03). Three patients presented wound infection and one patient had prosthesis infection. One postoperative death occurred in the HES group secondary to myocardial infarction leading to fatal cardiogenic shock.
Discussion
In patients undergoing hip arthroplasty, fl uid replacement with hydroxyethyl starch 130/0.4 resulted in higher rates of bleeding when compared to those that received lactated Ringer. Conversely, starch treated patients required less transfusion, and presented a lower rate of infection. The higher rates of bleeding attributed to the HES group did not compromise the clinical outcomes of these patients. Elective major orthopedic surgery was chosen because it offers a common and standard surgical setting that allowed the study design to be largely based on clinical routine. The crystalloid-colloid volume ratio of 2:1 was established based on previous studies that compared the effectiveness of colloids against crystalloids 18, 25, 26 .
In our study, the higher impact of colloids on platelet aggregation tests did not seem to result in worse clinical outcomes, as the HES group received less transfusion. The 31 Volume Replacement Therapy during Hip Arthroplasty using Hydroxyethyl Starch (130/0.4) Compared to Lactated Ringer Decreases Allogeneic Blood Transfusion and Postoperative Infection hypothesis for this fi nding is that colloids accounted for improved hemodynamic stability; therefore, few patients in this group needed transfusion.
Considering the deleterious effects produced by allogeneic transfusion in different clinical scenarios 27 and consistent data showing a relatively low impact of new generations of starch on coagulation 28 , HES administration would be an attractive alternative to traditional fl uid replacement in major orthopedic surgeries under spinal anesthesia.
Traditional protocols involve fl uid expansion with crystalloid and liberal protocol of allogeneic transfusion. In fact, evidence from previous studies showing benefi ts of allogeneic blood transfusion is deeply hindered by a signifi cant number of underpowered studies with a small-sized population. In addition, the TRICC trial (Transfusion Requirements in Critical Care) -the only large RCT that compared a restrictive versus a liberal transfusion strategy -was suffi ciently powered to favor a restrictive transfusional trigger in clinical ICU patients 11 . In a large orthopedic trial undertaken in 1999, a total of 2,640 hip and 1,305 knee arthroplasty patients were evaluated 29 . A total of 2,762 (69%) received transfusion, of which only 35% autologous and 25% allogeneic. The most important fi nding of this study was that the rate of wound infections was signifi cantly higher (4.2% vs. 1%) when comparing patients exposed to allogeneic and autologous transfusion, respectively 29 .
Nevertheless, common techniques that may reduce allogeneic blood transfusion during major surgeries -such as the acceptance of lower levels of hemoglobin before transfusion decision, routine use of acute normovolemic hemodilution (ANH), cell salvage and pharmacological haemorrhage control -are not systematically used in most countries 30, 37 . Although being extremely feasible, ANH is not largely employed. We have extensively investigated experimentally the effects of ANH on the heart 31 , lungs 32 and different organs 33 . In these experimental studies, results favored colloid over crystalloid fl uid replacement that concerns cellular and organ architecture preservation. In our study, however, patients submitted to hypervolemic hemodilution with starch 130/0.4 presented more bleeding than those who received moderate quantities of lactated Ringer. This could be the result of hemodilution and/or direct action of starch on the coagulation system. Considering the effects of hemodilution, Ruttman and colleagues 34 aimed to investigate whether hemodilution altered coagulation in patients scheduled to peripheral vascular surgery under regional anesthesia. Although much less volume was used in both groups compared to our study, the colloid group showed no coagulation disorder. In contrast, those who received more crystalloids presented more changes in the coagulation profi le measured by thromboelastography. They concluded that this was caused by plasmatic dilution determined by rapid crystalloid infusion. In our study, patients treated with starch showed more bleeding. This was possibly due to acute hemodilution, since 30 mL.kg -1 was employed, in an attempt to maintain the patient hemodinamically stable without the need for further transfusion. The direct effects of starch on hemostasis and coagulation should also be considered. The platelet aggregation test used in our investigation was signifi cantly affected and this fi nding stresses the more pronounced effects of starches on platelet function when compared to the effects on other components of the hemostatic system, as shown by several studies. Kozek-Langenecker et al. 35 described the molecular mechanism of starches on the coagulation system. According to this study, the low-molar substitution is the main determinant of increased metabolic degradation, which ascertains undesirable effects, particularly on hemostasis. Slowly degradable HES, characterized by high-and mediummolecular weight, determine plasmatic reduction on the levels of factor VIII and vWF. At the same time, it decreases platelet reactivity under two mechanisms: decrease in the availability of the platelet fi brinogen receptor glycoprotein IIb-IIIa and interference on platelet-linking properties of vWF. On the other hand, fast degradable HES solutions with medium-and low-molecular weight showed reduced effects on hemostasis. 33 Volume Replacement Therapy during Hip Arthroplasty In this context, Gandhi et al. 10 compared the safety of two starches (HES 130/0.4 vs. HES 670/0.75 in saline) during major orthopedic surgery 10 . The primary safety endpoints were calculated: total erythrocyte loss, the nadir factor VIII activity, and the nadir von Willebrand factor concentration within 2 hours of surgery completion. The total volume of colloid solution required for intraoperative volume replacement did not differ between HES 130/0.4 and hetastarch. The nadir factor VIII activity within 2 hours of the end of surgery decreased in both groups, but was lower for hetastarch than for HES 130/0.4 (p = .0499). For those who received more than 1,000 mL of colloid, von Willebrand factor levels also decreased in both groups within 2 hours of the end of surgery, but the concentration was lower for hetastarch than for HES 130/0.4. They concluded that HES 130/0.4 and hetastarch were equally effective as plasma volume expanders, with HES 130/0.4 showing a lesser effect on coagulation 10 . Our study showed a similar fi nding of the low impact of HES 130/0.4 on coagulation tests, except for platelet aggregation.
Ta b l e 3 Hematological Analysis of Patients
The impact of blood transfusion on infection rates was determined by several studies 11, 29 that correlated immunological interplay between blood transfusion and infection. 34 A. Hamaji et al.
In our study, the Ringer group required more transfusion and had a higher rate of infection. Four patients in this group had postoperative infection, and one of them was submitted to three surgical procedures combined with antibiotic therapy.
Fluid replacement with HES 130/0.4 resulted in reduced transfusion rates and in lower incidence of infection, compared to crystalloid solution, an outcome that suggests that colloid-induced hypervolemic hemodilution would be an attractive strategy to be applied in orthopedic surgery. 
